Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Joost

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of Invasive Cardiology|September 6, 2011
Intraventricular stent loss after interventional treatment of a coronary dissection--a case reportAlexander Joost, Peter Hunold, Joachim Weil
Expert Opinion on Pharmacotherapy|June 10, 2011
Candesartan cilexetil: an updateAlexander Joost, Heribert Schunkert, Peter Walter Radke
Current Pharmaceutical Design|May 14, 2008
Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary angiography and interventionsAlexander Joost, Volkhard Kurowski, Peter W Radke
World Journal of Cardiology|December 17, 2010
Drug eluting balloons for the treatment of coronary artery disease: What can we expect?Alexander Joost, Volkhard Kurowski, Peter W Radke
Deutsche Medizinische Wochenschrift (1946)|October 9, 2019
[Lemierre syndrome - a frequently overlooked infectious disease]Alexander Joost, Stefan Loose, Evelyn Kramme, et al.
Circulation|July 21, 2004
Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapyAdnan Kastrati, Nicolas von Beckerath, Alexander Joost, et al.
European Heart Journal|November 4, 2004
Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stentingOlga Gorchakova, Nicolas von Beckerath, Meinrad Gawaz, et al.
The American Journal of Cardiology|September 8, 2016
Impact of Initial Culprit Vessel Flow on Infarct Size, Microvascular Obstruction, and Myocardial Salvage in Acute Reperfused ST-Elevation Myocardial InfarctionAlexander Joost, Thomas Stiermaier, Charlotte Eitel, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 12, 2011
Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipientsPeter W Radke, Michael Joner, Alexander Joost, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 7, 2025
Distal access and procedural anticoagulation to prevent radial artery occlusion after coronary angiography - the randomised RAPID trialThomas Stiermaier, Matthias Grünewälder, Toni Pätz, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Invasive Cardiology|September 6, 2011
Intraventricular stent loss after interventional treatment of a coronary dissection--a case reportAlexander Joost, Peter Hunold, Joachim Weil
Expert Opinion on Pharmacotherapy|June 10, 2011
Candesartan cilexetil: an updateAlexander Joost, Heribert Schunkert, Peter Walter Radke
Current Pharmaceutical Design|May 14, 2008
Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary angiography and interventionsAlexander Joost, Volkhard Kurowski, Peter W Radke
World Journal of Cardiology|December 17, 2010
Drug eluting balloons for the treatment of coronary artery disease: What can we expect?Alexander Joost, Volkhard Kurowski, Peter W Radke
Deutsche Medizinische Wochenschrift (1946)|October 9, 2019
[Lemierre syndrome - a frequently overlooked infectious disease]Alexander Joost, Stefan Loose, Evelyn Kramme, et al.
Circulation|July 21, 2004
Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapyAdnan Kastrati, Nicolas von Beckerath, Alexander Joost, et al.
European Heart Journal|November 4, 2004
Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stentingOlga Gorchakova, Nicolas von Beckerath, Meinrad Gawaz, et al.
The American Journal of Cardiology|September 8, 2016
Impact of Initial Culprit Vessel Flow on Infarct Size, Microvascular Obstruction, and Myocardial Salvage in Acute Reperfused ST-Elevation Myocardial InfarctionAlexander Joost, Thomas Stiermaier, Charlotte Eitel, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 12, 2011
Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipientsPeter W Radke, Michael Joner, Alexander Joost, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 7, 2025
Distal access and procedural anticoagulation to prevent radial artery occlusion after coronary angiography - the randomised RAPID trialThomas Stiermaier, Matthias Grünewälder, Toni Pätz, et al.
Pageof 2